Chien‐Yuan Chen

5.0k citations
70 papers · 2.7k indexed · h-index 30
Topics
Acute Myeloid Leukemia Research (28 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers)Antifungal resistance and susceptibility (6 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Chien‐Yuan Chen

66 papers receiving 2.7k citations

Peers

Chien‐Yuan Chen
Comparison fields: 5 of 105
  • Hematology 1.4k
  • Molecular Biology 1.3k
  • Genetics 655
  • Oncology 366
  • Epidemiology 343
Replace Shang‐Yi Huang with:
Shang‐Yi Huang Taiwan
Gottfried Dölken Germany
Kyungja Han South Korea
Mark Heaney United States
Heinz Sill Austria
Joseph W. Fay United States
Lawrence G. Lum United States
Junichi Tsukada Japan
Rohtesh S. Mehta United States
Ralph Quinones United States
Chien‐Yuan Chen relative to Shang‐Yi Huang Taiwan Shang‐Yi Huang's profile →
Citations per field
00.5×1.5×
Shang‐Yi Huang · 1×
Citations per year

Countries citing papers authored by Chien‐Yuan Chen

Since Specialization
Citations

This map shows the geographic impact of Chien‐Yuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Yuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Yuan Chen more than expected).

Fields of papers citing papers by Chien‐Yuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Yuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Yuan Chen. The network helps show where Chien‐Yuan Chen may publish in the future.

Co-authorship network of co-authors of Chien‐Yuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Yuan Chen. A scholar is included among the top collaborators of Chien‐Yuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Yuan Chen. Chien‐Yuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 0
5 5
6 16
7 43
8 20
9 48
10 11
11 8
12 29
13 14
14 3
15 3
16 88
17 115
18 73
19 5
20 8

About Chien‐Yuan Chen

Chien‐Yuan Chen is a scholar working on Hematology, Genetics and Infectious Diseases, having authored 70 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers) and Antifungal resistance and susceptibility (6 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (655 citations) and Cancer Research (319 citations). Chien‐Yuan Chen has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Hwei‐Fang Tien, Jih‐Luh Tang, Woei Tsay, Ming Yao, Wen‐Chien Chou, Shang‐Yi Huang, Shang‐Ju Wu, Hsin‐An Hou, Mei‐Hsuan Tseng and Liang‐In Lin. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026